new glp-1 agonist Receptor Agonists: The Wave in Diabetes Management Upcoming wave of hormone-based therapies

Here, we provide a comprehensive review of the therapeutic potential of incretin mimetics and insulin in AD and PD.

Supports overall daily wellness

Learn why semaglutide & tirzepatide slow digestion, and discover lifestyle tips + Digest by Strive for natural, lasting relief.

Limited head-to-head studies compare established glucagon-like peptide-1 receptor agonists (GLP-1 RAs), dipeptidyl peptidase-4 inhibitors (DPP-4is), and sodium-glucose co-transporter-2 inhibitors (SGLT-2is) to insulin in the management of uncontrolled type 2 diabetes mellitus (T2DM)

Shima Hadidchi

Explore the main brands, common side effects, long term effects and key FAQs.